Notably, different alteration of HGFR, p-AKT, and p-FAK expression by targeting PTEN in both a PTEN blockade impassible group or a susceptible group should be further investigated to establish the fundamental signaling pathway in pancreatic cancer cells. The gene discussed is PTK2; the disease is familial pancreatic carcinoma.